Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Surg Infect (Larchmt) ; 21(2): 158-160, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31556841

RESUMEN

Background: Infections with Aeromonas spp. are a recognized complication of leech therapy for circulatory complications in replanted digits. Ciprofloxacin is commonly used empirically for Aeromonas coverage in such cases. Evolving resistance patterns of Aeromonas should be considered in designing an antibiotic strategy. Methods: Three consecutive patients with complicated replantations had site cultures yielding Aeromonas isolates resistant to ciprofloxacin. These cultures were analyzed to identify effective antibiotic agents. Results: Each Aeromonas isolate, and each additional site organism, was sensitive to cefepime. Conclusion: Our routine antibiotic coverage for leech application has been changed to cefepime. Aeromonas sensitivities and resistances should be monitored to adapt to future changes in appropriate antibiotics.


Asunto(s)
Aeromonas/efectos de los fármacos , Antibacterianos/farmacología , Farmacorresistencia Microbiana/efectos de los fármacos , Aplicación de Sanguijuelas/métodos , Reimplantación/métodos , Antibacterianos/uso terapéutico , Cefepima/farmacología , Cefepima/uso terapéutico , Ciprofloxacina/farmacología , Ciprofloxacina/uso terapéutico , Humanos , Aplicación de Sanguijuelas/efectos adversos , Pruebas de Sensibilidad Microbiana , Reimplantación/efectos adversos
2.
Ann Plast Surg ; 80(3 Suppl 2): S106-S112, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29461288

RESUMEN

Carbon monoxide (CO) is a small molecule poison released as a product of incomplete combustion. Carbon monoxide binds hemoglobin, reducing oxygen delivery. This effect is exacerbated in the burned pregnant patient by fetal hemoglobin that binds CO 2.5- to 3-fold stronger than maternal hemoglobin. With no signature clinical symptom, diagnosis depends on patient injury history, elevated carboxyhemoglobin levels, and alterations in mental status. The standard of care for treatment of CO intoxication is 100% normobaric oxygen, which decreases the half-life of CO in the bloodstream from 5 hours to 1 hour. Hyperbaric oxygen (HBO2) is a useful adjunct to rapidly reduce the half-life of CO to 20 minutes and the incidence of delayed neurologic sequelae. Because of the slow disassociation of CO from hemoglobin in the fetus, there is a far stronger indication for HBO2 in the burned pregnant patient than in other burn patient populations.Cyanide intoxication is often a comorbid disease with CO in inhalation injury from an enclosed fire, but may be the predominant toxin. It acts synergistically with CO to effectively lower the lethal doses of both cyanide and CO. Diagnosis is best made in the presence of high lactate levels, carboxyhemoglobin concentrations greater than 10%, injury history of smoke inhalation from an enclosed fire, and alterations in consciousness. While treatment with hydroxocobalamin is the standard of care and has the effect of reducing concomitant CO toxicity, data indicate cyanide may also be displaced by HBO2.Carbon monoxide and cyanide poisoning presents potential complications impacting care. This review addresses the mechanism of action, presentation, diagnosis, and treatment of CO and cyanide poisonings in the burned pregnant patient and the use of HBO2 therapy.


Asunto(s)
Intoxicación por Monóxido de Carbono/terapia , Cianuros/envenenamiento , Oxigenoterapia Hiperbárica/métodos , Complicaciones del Embarazo/terapia , Lesión por Inhalación de Humo/terapia , Unidades de Quemados , Intoxicación por Monóxido de Carbono/complicaciones , Servicios Médicos de Urgencia , Femenino , Humanos , Embarazo
3.
Ann Plast Surg ; 80(3 Suppl 2): S98-S105, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29461292

RESUMEN

Inhalation injury causes a heterogeneous cascade of insults that increase morbidity and mortality among the burn population. Despite major advancements in burn care for the past several decades, there remains a significant burden of disease attributable to inhalation injury. For this reason, effort has been devoted to finding new therapeutic approaches to improve outcomes for patients who sustain inhalation injuries.The three major injury classes are the following: supraglottic, subglottic, and systemic. Treatment options for these three subtypes differ based on the pathophysiologic changes that each one elicits.Currently, no consensus exists for diagnosis or grading of the injury, and there are large variations in treatment worldwide, ranging from observation and conservative management to advanced therapies with nebulization of different pharmacologic agents.The main pathophysiologic change after a subglottic inhalation injury is an increase in the bronchial blood flow. An induced mucosal hyperemia leads to edema, increases mucus secretion and plasma transudation into the airways, disables the mucociliary escalator, and inactivates hypoxic vasocontriction. Collectively, these insults potentiate airway obstruction with casts formed from epithelial debris, fibrin clots, and inspissated mucus, resulting in impaired ventilation. Prompt bronchoscopic diagnosis and multimodal treatment improve outcomes. Despite the lack of globally accepted standard treatments, data exist to support the use of bronchoscopy and suctioning to remove debris, nebulized heparin for fibrin casts, nebulized N-acetylcysteine for mucus casts, and bronchodilators.Systemic effects of inhalation injury occur both indirectly from hypoxia or hypercapnia resulting from loss of pulmonary function and systemic effects of proinflammatory cytokines, as well as directly from metabolic poisons such as carbon monoxide and cyanide. Both present with nonspecific clinical symptoms including cardiovascular collapse. Carbon monoxide intoxication should be treated with oxygen and cyanide with hydroxocobalamin.Inhalation injury remains a great challenge for clinicians and an area of opportunity for scientists. Management of this concomitant injury lags behind other aspects of burn care. More clinical research is required to improve the outcome of inhalation injury.The goal of this review is to comprehensively summarize the diagnoses, treatment options, and current research.


Asunto(s)
Quemaduras por Inhalación/terapia , Intoxicación por Monóxido de Carbono/terapia , Lesión por Inhalación de Humo/terapia , Quemaduras por Inhalación/patología , Intoxicación por Monóxido de Carbono/etiología , Humanos , Oxigenoterapia Hiperbárica/métodos , Respiración Artificial/métodos , Lesión por Inhalación de Humo/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA